Selective effects of aniracetam across receptor types and forms of synaptic facilitation in hippocampus
- 13 October 1991
- journal article
- research article
- Published by Wiley in Hippocampus
- Vol. 1 (4) , 373-380
- https://doi.org/10.1002/hipo.450010405
Abstract
Aniracetam reversibly increased synaptic responses mediated by the AMPA but not the NMDA subclass of glutamate receptors in hippocampus and was considerably more potent than structurally similar nootropics. The drug had greater effects on field excitatory postsynaptic potentials (EPSPs) in the dentate gyrus and CA1 region than it did in the CA3 region, suggesting that it differentiates between variants of the AMPA receptor. Ligand binding to glutamate receptors in synaptosomal membrane fractions was minimally changed by aniracetam. Finally, the percent facilitation produced by aniracetam in the CA1 region was not reduced by any of three treatments (4‐aminopyridine, changes in extracellular calcium concentrations, paired‐pulse stimulation) that affect release but, in accord with a previous report, was substantially decreased by long‐term potentiation. These results support the conclusion that aniracetam selectively increases the conductance of a subgroup of synaptic AMPA receptors in hippocampus and suggest that receptor changes underlie the expression of long‐term potentiation.Keywords
This publication has 25 references indexed in Scilit:
- Evidence that changes in spine neck resistance are not responsible for expression of LTPSynapse, 1991
- A Family of AMPA-Selective Glutamate ReceptorsScience, 1990
- Mossy fiber potentiation and long‐term potentiation involve different expression mechanismsSynapse, 1990
- Cloning by functional expression of a member of the glutamate receptor familyNature, 1989
- Rate‐limiting step for transmission at excitatory synapses in hippocampusSynapse, 1989
- Cognition activatorsMedicinal Research Reviews, 1988
- Induction of Synaptic Potentiation in Hippocampus by Patterned Stimulation Involves Two EventsScience, 1986
- Comparative Electrophysiological Investigations on Oxiracetam and PiracetamClinical Neuropharmacology, 1986
- Vincamine: A psychogeriatric agent blocking synaptic potentiation in hippocampusLife Sciences, 1982
- Estimates of quantal content during 'chemical potentiation' of transmitter releaseProceedings of the Royal Society of London. B. Biological Sciences, 1979